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ABSTRACT
Objective: The United States faces an opioid crisis. Integrating prescription drug monitoring programs into
electronic health records offers promise to improve opioid prescribing practices. This study aimed to evaluate
2 different user interface designs for prescription drug monitoring program and electronic health record inte-
gration.
Materials and Methods: Twenty-four resident physicians participated in a randomized controlled experiment
using 4 simulated patient cases. In the conventional condition, prescription opioid histories were presented in
tabular format, and computerized clinical decision support (CDS) was provided via interruptive modal dialogs
(ie, pop-ups). The alternative condition featured a graphical opioid history, a cue to visit that history, and nonin-
terruptive CDS. Two attending pain specialists judged prescription appropriateness.
Results: Participants in the alternative condition wrote more appropriate prescriptions. When asked after the ex-
periment, most participants stated that they preferred the alternative design to the conventional design.
Conclusions: How patient information and CDS are presented appears to have a significant influence on opioid
prescribing behavior.
Key words: user-computer interface, decision support systems, clinical, medical order entry systems, prescription drug monitor-
ing programs, pain management
INTRODUCTION
Opioid overdose deaths quadrupled between 1999 and 2016 in the
United States, accounting for more than half of drug overdose
deaths.1 Prescribed opioids are believed to have contributed to the
crisis: 1 in 10 patients prescribed opioids became dependent,2 4 in 5
heroin users started with an opioid prescription,3 and many opioid
prescriptions have been diverted.4
This is not the first opioid crisis in the United States—lawmakers
responded to the crisis of the 1960s by writing the Controlled
Substances Act of 1970, which set the contemporary framework for
controlling drugs with “abuse potential” via criminological and
medical institutions.5 In response to the current crisis, all 50 U.S.
states and Guam have developed prescription drug monitoring pro-
gram (PDMP) databases to track prescriptions of most controlled
substances, and to make patients’ prescription histories available to
licensed prescribers.6,7 Further, the U.S. Centers for Disease Control
and Prevention and other governing bodies have recommended or
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even required that prescribers verify each patient’s PDMP history
before prescribing opioids.8–10
In most states, PDMPs are provided via standalone websites; they
are not integrated with the electronic health records (EHRs) that most
prescribers now use to place medication orders. Therefore, accessing
PDMP information is often a tedious task: a prescriber must first lo-
cate the website, and then contend with strict password logistics, rigid
search engines, and cluttered information displays.7,11–13
There have been some efforts to integrate PDMPs into EHRs,14–17
which may address the difficulties locating and logging into PDMPs.
Whether this integration should be mandated has also been
discussed.17,18 However, little attention has been paid to where and
how PDMP information should be presented in the EHR, as well as
how clinical decision support (CDS) should be designed to augment
cognition while introducing minimal disruption to workflow.7,19,20
A conventional method of implementation would be to provide the
PDMP in a dedicated tab in the user interface and to present CDS via
interruptive modal dialogs (ie, pop-up alerts). Such a design is, how-
ever, susceptible to a number of issues known in the human factors
and health informatics literature. First, prescribers have difficulty read-
ing and interpreting PDMP reports (eg, owing to cluttered, disorga-
nized displays).7,12 Second, without contextual cues to draw
prescribers’ attention to the PDMP information, the tab may likely be
neglected.21 As for CDS, the problem of alert fatigue22 may arise:
when a CDS system issues too many alerts, and when many of them
are irrelevant, users tend to cease to pay attention to them.23 Further,
the literature suggests against restrictive designs such as modal dia-
logs24,25 because of their interruptive nature, and excessive use of
modal dialogs may have contributed to clinician dissatisfaction and
burnout.26–29
In this work, we applied human factors principles to improve the
design of PDMP-EHR integration. Human factors research aims
to develop technologies that fit users’ expectations, rather than
requiring users to conform to any given design. It has been widely
applied in health informatics to study a variety of applications such
as medical devices,30,31 EHRs,32 and computerized prescriber order
entry systems.33–37
In this study, we conducted a simulation experiment to compare
2 designs for PDMP-EHR integration. In the conventional design,
the patient’s controlled substance prescription history is presented in
tabular format, in a separate PDMP tab, and CDS advisories are pre-
sented in interruptive modal dialogs when an order is about to be
placed. In the alternative design, multiple contextual cues are pro-
vided to draw prescribers’ attention to PDMP information, along
with noninterruptive CDS presented as part of the ordering process.
We subsequently provide details and illustrations of these 2 designs.
We hypothesized that the alternative design would increase the
appropriateness of physician prescriptions, because it was intended
to facilitate “information foraging,”21 convey information through
cognitively efficient graphic representation,7,38 and deliver CDS
early on in the prescribing process.39 We also hypothesized that
physicians would prefer the alternative design, the alternative condi-
tion would require less time to use, and physicians would visit the
PDMP tab more often under the alternative condition when infor-
mation was available. Next, we describe the 2 designs and the proto-
col for the simulated experiment.
MATERIALS AND METHODS
Two competing designs for PDMP-EHR integration
Demonstrations of the 2 designs are available online (https://www.
ics.uci.edu/mihussai/demos/2019-simulation-study/). In Table 1,
we summarize the features present in each of the designs. Briefly, the
conventional design (Figure 1) has a dedicated PDMP tab, which
Table 1. Feature description and comparison
Feature Conventional Alternative
Medication list Displays medication history and current medica-
tions.
Cue for availability of PDMP information. When PDMP data are
available for the patient, a noninterruptive cue appears, with a
shortcut to the PDMP tab ‹.
Prescribed controlled
substances tab
Displays a table, showing date filled, prescribing
physician, drug category, and MMEs.
Graphical presentation of opioid history. The tabular PDMP data
are supplemented with a stacked bar chart showing MMEs and
distinct prescribers in the past year ›.
Medication ordering
entry
The user orders medications by searching for a
drug, and then selecting a route, dose, fre-
quency, and duration. After the prescription is
fully defined and before the order is placed,
the system pops up CDS.
Modal dialogs. CDS is delivered via modal dia-
logs. The user clicks “Cancel” to return to the
ordering screen, or “Order” to override the
alert.
The user is guided by 3 types of contextual cues:
Query expansion suggestions. When ordering a medication, if one
types “fent” into the search bar, medication classes similar to the
fentanyls, such as “analgesic combinations” and “NSAIDs,” ap-
pear below the search results. The query expansion algorithm is
based on the RxNorm40 classification system ﬁ.
Contextual prescription opioid history. When one adds an opioid
to the Your Options panel, the graphical prescription opioid his-
tory appears on the right side of the screen ﬂ.
Medication suggestions. The CDC Guideline recommends first
seeking alternatives to opioids, then starting with low MMEs.6
Accordingly, if one adds a high-MME opioid such as fentanyl to
the Your Options panel, the system would display a generic re-
minder to use lower-risk pain medications, such as acetamino-
phen, ibuprofen, and codeine. One can then add 1 or more of
these medications to the Your Options panel as potential substi-
tutes .
CDC: Centers for Disease Control and Prevention; CDS: clinical decision support; MME: milligram morphine equivalent; PDMP: prescription drug monitoring
program.
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presents controlled substance prescription history in a tabular
format, as is typical of PDMPs.7 It also features a typical CDS de-
sign, which presents text-only modal dialogs immediately before the
order is placed.33,39 The alternative design also presents a noninter-
ruptive cue to draw the prescriber’s attention to PDMP information,
a graphical opioid prescription history along with tabular PDMP
data, and noninterruptive CDS advisories presented as part of the
ordering process (Figure 2).
In the experiment, participants completed 4 scenarios, developed
by an attending pain specialist (AMN). These scenarios, and accom-
panying graphical prescription opioid histories, are provided in the
Supplementary Appendix. We created mock patient interview videos
to present the scenarios, each of which featured a white male actor
between 28 and 56 years of age, to minimize potential discrimina-
tory prescribing effects—prior research41,42 has found that opioids
are prescribed less frequently for black and female patients.
Study setting and experiment protocol
All study participants were either anesthesiology or physical medi-
cine and rehabilitation (PM&R) residents; practitioners in these dis-
Figure 1. Conventional design, which presents the patient’s medication history as a simple list (top), the prescription drug monitoring program information in a
tabular format on a separate tab (middle), and interruptive modal dialogs for delivering decision support (bottom).
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ciplines commonly prescribe opioids. All participants had completed
at least 1 year of residency training at a large academic medical cen-
ter in Southern California. Researchers presented the study during
monthly resident meetings and recruited in person. All eligible resi-
dents but 1 agreed to participate. Half of the participants were ran-
domly assigned to use 1 of the designs. At the beginning of the
experiment, participants viewed a tutorial video about how to use
the simulated EHR. Then, participants proceeded to the first patient
interview video, reviewed the patient’s medical records, and placed
medication orders. The experiment concluded after the participant
completed all 4 patient scenarios, which were presented in a random
order. In this article, we refer to each instance of a participant com-
pleting a scenario as a trial, in accordance with how it is described
in experimental psychology studies. This portion of the study took
approximately half an hour, with no apparent differences in time be-
tween the 2 conditions.
After the experiment, participants who used the conventional de-
sign were shown a video tour of the alternative design, and vice
versa. They were then asked to preferentially compare the 2 designs,
and to provide a reason for their preference. Participants did not
Figure 2. Alternative design, featuring a contextual cue when prescription drug monitoring program information is available (‹), a graphical presentation of opi-
oid prescription history (›), and noninterruptive decision support delivered as contextual cues as part of the ordering process (ﬁ, ﬂ, and ).
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receive compensation or an honorarium for their participation.
The institutional review board of the University of California, Irvine
reviewed the research protocol of the study and determined that it
met the exemption criteria.
Data collection and appropriateness review
We implemented a tracking mechanism in both designs to record
mouse clicks as well as timestamps of interaction events in order to
measure the time spent between actions (eg, starting an order and
placing an order).
In order to assess whether the pain medication orders placed for
each scenarios were appropriate, we developed an appropriateness
panel review, based on the process described by McCoy et al.43
First, 2 pain specialists (AMN, BY) created a scoring rubric (in-
cluded in Supplementary Appendix) through consensus develop-
ment. Then, they independently reviewed the prescriptions placed
for each trial. During the entire process, reviewers were blinded to
the experimental condition (alternative vs conventional) in which
each prescription was written. Interrater reliability was assessed us-
ing Cohen’s kappa.44 If there were scoring differences, they were
reconciled through discussion and consensus development.
Data analyses
We used JASP v. 0.10.2 (JASP Team, Amsterdam, the Netherlands) to
conduct a 2-way mixed-effects analysis of variance (ANOVA) analysis
of appropriateness. We tested the sphericity and equality of variance
assumptions using Mauchly’s and Levene’s tests, respectively.
We used a chi-square test to evaluate participants’ design prefer-
ences. We also conducted a mixed-effects ANOVA to assess time re-
duction from each trial to the next, between conditions, to examine
the learning effect and time efficiency of each of the designs.
Further, we conducted a 1-way mixed-effects ANOVA to test to
assess whether those in the conventional condition visited the PDMP
tab less often than their peers in the alternative condition when the
patient’s PDMP information was available. We also analyzed the
usage of different features presented in the interfaces of the 2 condi-
tions (eg, recommended alternative medications or pop-up alerts).
RESULTS
Participant demographics
Seventeen (71%) of the participants were anesthesiology residents
and the other 7 (30%) were PM&R residents. We randomly
assigned 9 (53%) of the anesthesiology residents and 3 (43%) of the
PM&R residents to the conventional condition, and the rest to the
alternative condition. Among the participants who reported demo-
graphic data, the mean age was 31 (range, 26–38) years of age; there
were 8 (40%) women and 12 (60%) men. Fifty-five percent (n ¼ 10)
of them were White, 35% (n ¼ 7) were Asian, and 8% (n ¼ 2) were
Black or African American. The Supplementary Appendix provides
additional demographic details.
Appropriateness analysis
Participants completed 94 trials in total; 2 were incomplete due to
loss of network connectivity. Interrater reliability was high between
the 2 attending physicians’ appropriateness ratings (Cohen’s
j¼0.93).44
The results of our 2-way mixed-effects ANOVA analysis are
shown in Table 2. According to these results, there was a borderline
significant effect of the experimental condition, which explained
14% of the variance (F1,18 ¼ 4.40, P¼ .05, g2 > .14); prescribers
who used the conventional design achieved lower scores (3.94 6
1.96) than those who used the alternative design (4.85 6 1.84). Fur-
ther, there was a significant main effect of specialty, which
explained 28% of the variance (F1,18 ¼ 8.73, P < .05, g2 > .28).
Overall, anesthesiology residents received higher appropriateness
scores (4.806 1.83) than PM&R residents (3.436 1.86).
Table 2. Two-way mixed-effects analysis of variance analysis of prescription appropriateness
Sum of Squaresa df Mean Square F P g2
Between-participants effects
Condition 18.546 1 18.546 4.398 .050 .140
Specialty 36.819 1 36.819 8.732 .008 .278
Condition  Specialty 1.113 1 1.113 0.264 .614 .008
Residual 75.897 18 4.217
Within-participants effects
Scenario 76.292 3 25.431 13.955 <.001 .242
Scenario  Condition 5.732 3 1.911 1.049 .379 .018
Scenario  Specialty 0.411 3 0.137 0.075 .973 .001
Scenario  Condition  Specialty 2.061 3 0.687 0.377 .770 .007
Residual 98.406 54 1.822
aType III sum of squares.
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Figure 3. Appropriateness scores by specialty and experimental condition.
PM&R: physical medicine and rehabilitation.
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There were no significant interaction effects. This analysis withstood
Mauchly’s test (P> .05) and Levene’s test (P> .05). As shown in Fig-
ure 3, those in the alternative condition tended to receive higher scores.
Participants’ preferences
As described previously, researchers showed a video of the alterna-
tive design to participants randomly assigned to the conventional
condition, and vice versa. Among those who provided a preference,
7 (70%) in the conventional condition stated that they preferred the
alternative design and 9 (81%) in the alternative condition preferred
it to the conventional design. Using a chi-square test, we found this
result to be statistically significant (n¼21; v21 ¼ 5.74, P < .05).
The top reason provided by the participants for preferring the alter-
native design was the visual representation of PDMP information,
followed by its flexibility in interaction, and participants’ aversion
to modal dialogs.
Trial duration and feature usage
In our mixed-effects ANOVA analysis of time, while we detected a
statistically significant overall reduction in trial completion time as
participants progressed through the 4 trials (144 seconds vs 135 sec-
onds vs 89 seconds vs 91 seconds; F3,60 ¼ 6.24, P < .001), we did
not detect a statistically significant difference in trial completion
time between the 2 conditions. We also did not detect an interaction
between trial progression and experimental condition.
As mentioned in the Materials and Methods section, we con-
ducted a 1-way mixed-effects ANOVA analysis to measure the influ-
ence of the experimental condition on whether participants checked
the PDMP tab when information was available. We found a signifi-
cant interaction effect of scenario and experimental condition on
whether the participant visited the PDMP tab—meaning that the de-
sign and the presence of a PDMP history produced the effect to-
gether—which explained 10% of the variance (F3,60 ¼ 3.44, P < .05,
g2 ¼ .10). Scenarios 3 and 4 were the only scenarios in which PDMP
information was available; both patients had been prescribed opioids
in the past year. In these scenarios, participants in the conventional
condition neglected to visit the PDMP tab 58% of the time, whereas
their peers in the alternative condition neglected to visit the tab only
8% and 27% of the time, respectively. There were no main effects,
as expected. Levene’s test did not pass under scenario 3 (P < .05).
In the conventional condition, participants overrode 45 of 47
(96%) modal dialogs. In the alternative condition, the patient’s
PDMP information was available in 23 trials. In 14 (61%) of these
cases, participants clicked the PDMP shortcut button (Figure 2, ‹).
In another 6 (26%) trials, they clicked the PDMP tab directly, rather
than using the shortcut. Among the other features provided in the al-
ternative condition, alternative medication suggestions were barely
clicked, and search suggestions were never used. However, we do
not know whether the information presented on screen had an influ-
ence on participants’ prescribing decisions.
DISCUSSION
To combat the opioid crisis, there is a broad consensus that it is im-
perative to integrate PDMP into EHRs to make it easier for prescrib-
ers to access patients’ prescription history of controlled substances
at the point of care.7,11–13 However, how PDMP information should
be presented in the EHR, and how this information should be opti-
mally incorporated into clinicians’ workflow and decision-making
processes, have remained understudied.
As mentioned previously, the primary approach to presenting
medication safety alerts is through modal dialogs. Modal dialogs are
relatively easy to implement, and there seems to be a perception that
modal dialogs—because of their interruptive nature—are an effec-
tive means of obtaining clinicians’ attention, leading to a higher like-
lihood of actions. However, there has been an extensive body of
literature suggesting that alerts delivered through modal dialogs are
frequently overridden,22,45 much like in our study, in which partici-
pants overrode 96% of modal dialogs. Further, modal dialogs are a
significant contributing factor to clinician frustration,46 burnout,47
and potentially unsafe prescribing practices.27
Alternative design improved prescription
appropriateness
In our study, participants who used the alternative design for inte-
grating PDMP information into the EHR, which features noninter-
ruptive, contextual cues, wrote more appropriate pain medication
prescriptions than did those who used an interruptive, modal dia-
log–based design, as we expected. This result suggests that attention
to interactive design can improve the effectiveness of PDMP-EHR
integration while minimizing disruption to workflow and clinicians’
decision-making processes.
Participants preferred the alternative design
Most participants preferred the contextual cue-based version, again
as expected. The results of participant feedback suggest that partici-
pants found the graphical PDMP display to be valuable, and they
also liked the fact that interaction with the system in the alternative
design was more flexible. In related research, prescribers have stated
that they are unlikely to check the database unless they see a
legitimate reason to do so.7,11,12 We believe that the PDMP history
indicator provided one such reason: the fact that the database actu-
ally had some information to offer.
Contextual information preferable to direct persuasion
While the alternative condition did not appear to save time, it also
did not appear to increase the time burden. It appears, then, that the
alternative condition allowed physicians to make better use of their
time, as measured by appropriateness. For example, according to
our usage statistics, those in the alternative design condition were
far more likely to visit the PDMP tab when information was
available, as we expected; we attribute this to the PDMP history in-
dicator, which participants frequently clicked.
Further, direct persuasion features (eg, modal dialogs and alter-
native medication recommendations) were almost always ignored.
We believe that alternative medication recommendations could be
more acceptable if they were more tuned to the patient’s chief com-
plaint, problem list, or diagnoses—developing such a recommender
system would require careful research in its own right.
The relative apparent efficacy of those “guiding” features, such
as the PDMP history cue and the visual representation of PDMP
data, seems to lend credence to design principles such as “anticipate
clinician needs and bring information to clinicians at the time they
need it.”48 We also note that participants said they liked the alterna-
tive design’s flexibility. By this, we believe that they were referring
to its support for flexible task wayfinding,49 the process by which a
user explores the structure of a task, such as composing a medica-
tion order. The alternative design allowed users to move quite freely
between the “high level” (eg, compiling medication options and reg-
imens) and the “low level” (specifying order details, such as route,
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dose, and frequency). By contrast, the conventional condition was
more regimented; it required the user to fully specify route, dose,
and frequency as soon as a medication was selected. We believe that
the alternative design’s support for flexible task wayfinding contrib-
uted to the overall improvement in appropriateness.
We conclude that alert fatigue continues to be a barrier to realiz-
ing the efficacy of CDS systems. Future research should seek alterna-
tive means of delivering decision-supporting information, such as
through contextual cues.
Limitations
First, our simulation apparatus only displayed generic names of the
medications, whereas most commercial EHRs display both generic
and brand names. However, because generic names were presented
in both conditions (alternative and conventional), we do not believe
that it influenced the outcomes of the study. Second, both attending
physicians who scored the results are anesthesiologists. This might
explain why the anesthesiology residents received slightly higher
overall scores than the PM&R residents did. Third, participants
were all resident physicians. Therefore, the results may not be gener-
alizable to more experienced participants, or physicians in special-
ties other than anesthesiology and PM&R. Fourth, our study was
designed to evaluate multiple user interface design features; further
research is needed to isolate which features contributed more to the
overall effect. Further, this was an experimental study conducted in
a simulated setting; further evaluation in realistic clinical environ-
ments is needed. Last, it should be acknowledged that certain U.S.
states prohibit PDMP-EHR integration by law. Alternative methods
for facilitating provider access to PDMP information may need to be
developed for these states, or lawmakers may consider allowing
some form of integration given the improved information utility.
CONCLUSION
With PDMP-EHR integration efforts projected to be underway
across the United States, it would be prudent to consider using hu-
man factors principles to ensure such integration is not only useful
but also usable, in order to achieve its maximum benefits. In this
study, we found that an alternative design using graphical presenta-
tion of PDMP data and contextual cues resulted in improved pain
prescribing compared with a conventional design that features tabu-
lar data display and modal dialogs for presenting CDS. Based on
these results, we conclude that the effectiveness of PDMP-EHR inte-
gration is critically dependent on interactive design.
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